Vistagen Therapeutics (VTGN) Technical (Analysis) Reports Vistagen Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Vistagen Therapeutics (VTGN)
Technical Analysis Report for USA stock VTGN Vistagen Therapeutics. Dated: 24 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock VTGN Vistagen Therapeutics then click here. or read Experts views on Vistagen Therapeutics or Forecast & share price targets of Vistagen Therapeutics
Vistagen Therapeutics Opened at 0.22 and Closed at: 0.23, which is 0% of previous session's close. It moved within a range of 0.22 and 0.23
The session was a Bullish session with an average volume of 1150600, which is 0% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.23 and resistance for tomorrow is 0.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.22, 0.22 resistance for tomorrow's hourly charts is 0.23, 0.24
10 Day SMA for Vistagen Therapeutics (VTGN) is 0.23 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Vistagen Therapeutics (VTGN) is 0.27 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Vistagen Therapeutics (VTGN) is 0.48 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.54 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Vistagen Therapeutics is 1.46 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Vistagen Therapeutics is at 0.27 and 200 DMA is at 1.46, while 50 DMA and 100 DMA are at 0.48 and 0.54 respectively
Vistagen Therapeutics (VTGN) moving average of 20 SMA is at 0.27 and 20 EMA is at 0.29
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Fri Jul | 0.23 | 0.27 | 0.29 |
| 24 Fri Jul | 0.23 | 0.29 | 0.3 |
| 23 Thu Jul | 0.23 | 0.31 | 0.31 |
| 22 Wed Jul | 0.23 | 0.33 | 0.32 |
| 21 Tue Jul | 0.23 | 0.35 | 0.33 |
| 20 Mon Jul | 0.23 | 0.37 | 0.34 |
Vistagen Therapeutics (VTGN) moving average of 50 SMA is at 0.48 and 50 EMA is at 0.45
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Fri Jul | 0.23 | 0.48 | 0.45 |
| 24 Fri Jul | 0.23 | 0.49 | 0.46 |
| 23 Thu Jul | 0.23 | 0.49 | 0.47 |
| 22 Wed Jul | 0.23 | 0.5 | 0.48 |
| 21 Tue Jul | 0.23 | 0.51 | 0.49 |
| 20 Mon Jul | 0.23 | 0.52 | 0.5 |
Vistagen Therapeutics (VTGN) moving average of 100 SMA is at 0.54 and 100 EMA is at 0.63
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Fri Jul | 0.23 | 0.54 | 0.63 |
| 24 Fri Jul | 0.23 | 0.54 | 0.64 |
| 23 Thu Jul | 0.23 | 0.55 | 0.65 |
| 22 Wed Jul | 0.23 | 0.55 | 0.66 |
| 21 Tue Jul | 0.23 | 0.55 | 0.67 |
| 20 Mon Jul | 0.23 | 0.56 | 0.68 |
Vistagen Therapeutics (VTGN) moving average of 200 SMA is at 1.46 and 200 EMA is at 1.18
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Fri Jul | 0.23 | 1.46 | 1.18 |
| 24 Fri Jul | 0.23 | 1.47 | 1.19 |
| 23 Thu Jul | 0.23 | 1.49 | 1.2 |
| 22 Wed Jul | 0.23 | 1.51 | 1.21 |
| 21 Tue Jul | 0.23 | 1.53 | 1.22 |
| 20 Mon Jul | 0.23 | 1.54 | 1.23 |
Humana Inc has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Humana Inc, about 69.85% more returns!
Edwards Lifesciences has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 60.36% more returns!
Dentsply Sirona has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 89.24% more returns!
Vertex Pharmaceuticals has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 65.28% more returns!
Viking Therapeutics has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Viking Therapeutics, about 57.7% more returns!
Tiziana Life has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 42.1% more returns!
Sonoma Pharmaceuticals has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Sonoma Pharmaceuticals, about 62.42% more returns!
Sol Gel has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Sol Gel, about 79.89% more returns!
Ultragenyx Pharmaceutical has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 57.42% more returns!
Intellia Therapeutics has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 34.3% more returns!
Kura Oncology has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 64.45% more returns!
Iradimed Corporation has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 70.19% more returns!
Halozyme Therapeutics has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 75.89% more returns!
Geron Corporation has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Geron Corporation, about 79.66% more returns!
Fulgent Genetics has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 65.55% more returns!
Curis Inc has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Curis Inc, about 1081.1% more returns!
Benitec Biopharma has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Benitec Biopharma, about 60.05% more returns!
Agenus Inc has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Agenus Inc, about 159.9% more returns!
Acadia Healthcare has performed better than Vistagen Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 94.37% more returns!
Vistagen Therapeutics Technical analysis of indicators
Price action analysis of Vistagen Therapeutics (VTGN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vistagen Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Vistagen Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Vistagen Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Vistagen Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Vistagen Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.23 and Vistagen Therapeutics VTGN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vistagen Therapeutics VTGN stock. Volume based technical analysis of Vistagen Therapeutics VTGN stock is negative.
Vistagen Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock VTGN Vistagen Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And VTGN Experts View which covers a lot of information including buying and selling signals
VTGN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Vistagen Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Vistagen Therapeutics (VTGN) Technical (Analysis) Reports Vistagen Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


